Related by context. All words. (Click for frequent words.) 71 allogeneic transplant 69 allogeneic stem cell 69 autologous transplants 68 anthracycline taxane 68 allogeneic HSCT 67 autologous hematopoietic stem cell 67 allogeneic transplants 67 allogeneic bone marrow 67 myeloablative 66 autologous SCT 66 transplantation HCT 66 cytoreduction 66 thoracoscopic lobectomy 65 concurrent chemoradiation 65 colorectal cancer liver metastases 65 chemoembolization 65 HLA matched 64 leukapheresis 64 antithymocyte globulin 64 mismatched bone marrow 64 autologous stem cell 64 lenalidomide Revlimid R 63 autologous transplantation 63 alkylating agent 63 hepatectomy 63 radioiodine therapy 63 transplanted islets 63 transarterial 63 Surgical resection 63 recurrent glioblastoma multiforme 63 adeno associated viruses 63 immunosuppressant drug 63 pig islets 63 intra arterial chemotherapy 63 subconjunctival injection 63 neoadjuvant chemotherapy 63 mutated K ras 63 undergoing hematopoietic stem 62 allogeneic hematopoietic stem cell 62 thalidomide Thalomid 62 anthracycline unless 62 cisplatin resistant 62 noninvasive outpatient 62 hepatic metastases 62 bevacizumab Avastin ® 62 allogeneic hematopoietic cell 62 pegylated alpha interferon 62 Gleevec resistant 62 GPIIb IIIa 62 HepaMate 62 debulking surgery 62 5-fluorouracil/leucovorin 62 gemcitabine Gemzar 62 surgical resection cavity 62 radiochemotherapy 62 haematopoietic stem cell 62 MGd 62 liver resection 62 chemotherapy cisplatin 61 radiolabeled antibodies 61 transarterial chemoembolization 61 allogeneic 61 PROCHYMAL 61 relapsed MM 61 mTOR inhibitors 61 peritoneal carcinomatosis 61 mesenchymal stem cell 61 prostate carcinoma 61 Platinol ® cisplatin 61 targeted antifolate 61 Hematopoietic stem cell 61 immunosuppressive regimen 61 Gliadel Wafer 61 postoperative chemotherapy 61 external beam radiotherapy 61 tumor resection 61 TNF alpha antagonist 61 metastatic GIST 61 pegylated liposomal doxorubicin 61 gemcitabine cisplatin 61 Doxil ® 61 anthracycline containing 61 syngeneic 61 unresectable tumors 61 radiation chemoradiation 61 standard chemotherapy regimens 61 humanised monoclonal antibody 61 Litx 61 intracoronary infusion 61 immunosuppressive medication 61 receptor tyrosine kinase inhibitor 61 tenecteplase 61 multiple myeloma MM 61 preoperative chemotherapy 61 hematopoietic cell 61 allogeneic SCT 61 pancreatic adenocarcinoma 61 reinfusion 61 colorectal liver metastases 61 bortezomib Velcade 61 nephrectomy 61 thalidomide dexamethasone 61 papillary renal cell carcinoma 61 rHuEPO 61 autologous bone marrow 61 intraductal 61 Autologous 61 orchiectomy 61 radiofrequency ablation RFA 61 calcineurin inhibitor 61 estramustine 61 GIST tumors 61 receiving highly emetogenic 60 aromatase inhibitor therapy 60 Islet transplantation 60 Tacrolimus 60 Breast conserving 60 cystectomy 60 metastatic malignant 60 Umbilical cord stem cells 60 allogenic 60 rhBMP 2 60 HIPEC 60 chemotherapeutic regimens 60 oral clodronate 60 underwent resection 60 castrate resistant 60 thymectomy 60 R0 resection 60 Dacogen decitabine 60 partial remissions 60 Bone marrow transplantation 60 EGFR TKI 60 Velcade bortezomib 60 cilengitide 60 non mutated KRAS 60 stem cell engraftment 60 IAP inhibitor 60 Azacitidine 60 radical nephrectomy 60 Islet cell 60 transplantation ASCT 60 cyclophosphamide chemotherapy 60 adjuvant cisplatin 60 metastatic malignant melanoma 60 basiliximab 60 cisplatin gemcitabine 60 enucleation 60 antiangiogenic therapy 60 chemoradiation therapy 60 orchidectomy 60 Islet cells 60 pluripotent embryonic 60 intradermal injections 60 antitumor effect 60 5 fluorouracil leucovorin 60 Bacillus Calmette Guerin BCG 60 adult mesenchymal stem 60 relapsed ALL 60 Hepatocellular Carcinoma HCC 60 immunologically compatible 60 immunotoxin 60 gefitinib Iressa 60 ribavirin RBV 60 LHRH receptor positive 60 reimplantation 60 paclitaxel Taxol ® 60 adjuvant radiotherapy 60 egg retrieval 60 gastrointestinal stromal tumors GIST 60 adjuvant radiation 60 underwent surgical resection 60 urothelial cancer 60 sorafenib Nexavar 60 hA# 60 DCVax Brain 60 renal tumors 60 YONDELIS 60 renal transplantation 60 anagrelide 60 underwent liver transplantation 60 lenalidomide dexamethasone 60 bone marrow aspirate 60 metastatic bladder 60 allogenic stem cell 60 transplanted bone marrow 60 pamidronate 60 folinic acid 60 daily subcutaneous injections 60 kidney urologic 60 PEGylated interferon 60 adriamycin 59 alkylating 59 MDS AML 59 rituximab Rituxan 59 Liver transplantation 59 xenograft 59 pancreatic tissue 59 cisplatin chemotherapy 59 cranial radiation 59 gastrointestinal stromal tumors 59 Accelerated Partial Breast Irradiation 59 neoadjuvant 59 CHOP chemotherapy 59 stage IIIb IV 59 advanced nonsquamous NSCLC 59 chemoresistant 59 cidofovir 59 BCG refractory 59 intradermal injection 59 erlotinib Tarceva ® 59 idarubicin 59 esophagectomy 59 de novo kidney transplant 59 Xelox 59 chemoradiotherapy 59 edifoligide 59 recurrent metastatic 59 transplant ASCT 59 donor cornea 59 pegylated interferon alfa 59 SpyGlass System 59 azacytidine 59 resected pancreatic cancer 59 thymic carcinoma 59 rituximab Rituxan ® 59 pneumonectomy 59 total abdominal hysterectomy 59 liposomal formulation 59 trabectedin 59 curative therapy 59 angiogenic therapy 59 Degarelix 59 engineered bladders 59 curative resection 59 orthotopic 59 ER CHOP 59 trans retinoic acid 59 relapsed leukemia 59 PSMA ADC 59 biliary tract cancer 59 antiangiogenic agent 59 bone marrow stem cell 59 oligodendrocyte progenitor cells 59 pancreatic transplantation 59 glycoprotein IIb IIIa inhibitors 59 neoadjuvant therapy 59 dimensional conformal radiation 59 liposomal doxorubicin 59 chemotherapeutic regimen 59 HepaMate ™ 59 MAGE A3 ASCI 59 BrachySil TM 59 HBV vaccine 59 intra arterial 59 targeted radiotherapeutic 59 transplantation HSCT 59 nutlin 3a 59 anti angiogenic agents 59 allogeneic HCT 59 allogeneic cell 59 bone marrow derived mesenchymal 59 Allogeneic 59 TroVax ® 59 ELACYT 59 liver metastasis 59 sarcomatoid 59 galiximab 59 pelvic lymphadenectomy 59 glutamic acid decarboxylase 59 cytotoxic therapy 59 chronic granulomatous disease 59 mitoxantrone chemotherapy 59 FOLFOX chemotherapy 59 stem cell transplantations 59 endoscopic resection 59 NOD SCID mice 59 miglustat 59 epirubicin cyclophosphamide 59 intravesical infusion therapy 59 recurrent glioblastoma 59 intratumoral injection 59 pancreatic carcinoma 59 PSA nadir 59 SCIg 59 pancreatic resection 59 percutaneous drainage 59 corneal graft 59 busulfan 59 epoetin alpha 59 ChronVac C R 59 islet transplants 59 corifollitropin alfa 59 tumor angiogenesis inhibitors 59 NF kB pathway 59 rtPA 59 previously untreated follicular 59 docetaxel chemotherapy 59 trans urethral resection 59 laparoscopic nephrectomy 59 Phe restricted diet 59 prostate adenocarcinoma 59 OMP #R# 59 docetaxel Taxotere ® 59 reinnervation 59 haematologic 59 donor marrow 59 Mesenchymal 59 sunitinib Sutent 59 HepDirect prodrug 59 androgen ablation 59 HSCT 59 vinca alkaloid 59 Bezielle 58 oral rivaroxaban 58 goserelin 58 NovoTTF 58 insulin secreting cells 58 superficial bladder cancer 58 Allovectin 7 ® 58 islet transplant 58 tiuxetan 58 irinotecan chemotherapy 58 FUSILEV enhances 58 via intradermal injections 58 radiotherapy RT 58 resectable 58 recurrent prostate cancer 58 flavopiridol 58 stem cell transplant 58 MYLOTARG 58 anti thymocyte globulin 58 autologous tissue 58 carmustine 58 immunomodulatory therapy 58 colorectal carcinoma 58 cytoreductive surgery 58 Bendamustine 58 hMG 58 DCVax ® Brain 58 Alocrest 58 submandibular gland 58 BRAF inhibitors 58 TACE 58 experimental autoimmune encephalomyelitis 58 Torisel 58 chemosensitizer 58 pentostatin 58 radiolabeled TM# 58 antibody MAb 58 bone grafting procedures 58 Temodar ® 58 neoplastic cells 58 Panzem NCD 58 CsA 58 Vascugel 58 imatinib therapy 58 CYT# potent vascular disrupting 58 nonmyeloablative 58 enzyme inhibitor 58 non myeloablative 58 paclitaxel Taxol R 58 AFRS TM 58 FLT3 ITD 58 immune suppressing 58 dasatinib Sprycel 58 percutaneous injection 58 steroid refractory 58 antimetabolite 58 TTF Therapy 58 haematopoietic 58 hematopoietic reconstitution 58 metastatic colorectal 58 nonsmall cell lung cancer 58 etoposide 58 remission CR 58 systemic ALCL 58 taxane therapy 58 pegylated interferon peg IFN 58 erythropoietic 58 malignant pleural mesothelioma 58 ureteroscopy 58 pediatric acute lymphoblastic 58 intracavitary 58 biochemical relapse 58 5 Fluorouracil 58 metastatic lung cancer 58 cell transplantation 58 trastuzumab Herceptin 58 Cloretazine 58 anti CD3 antibody 58 paclitaxel cisplatin 58 dose dexamethasone 58 anti angiogenic agent 58 bispecific antibody 58 orally administered inhibitor 58 ixabepilone 58 interferon therapy 58 nephrectomies 58 administered systemically 58 keratoplasty 58 IMiDs ® compound 58 metastatic gastric 58 stem cell transplantation 58 valve implantation 58 bone marrow aspiration 58 domino transplant 58 Campath alemtuzumab 58 Inhaled nitric oxide 58 intravesical therapy 58 tumor excision 58 receiving immunosuppressive therapy 58 MYDICAR ® 58 surgical debulking 58 beam radiotherapy 58 hESC derived 58 hyperinsulinemic euglycemic clamp 58 mononuclear 58 bone marrow aspirates 58 PEGylated 58 Neo Bladder Augment 58 extrapleural pneumonectomy 58 cultured stem cells 58 GRNOPC1 contains 58 uricase 58 hypervascular tumors 58 taxane chemotherapy 58 Radical prostatectomy 58 ureteral stones 58 elective PCI 58 TKI therapy 58 saline placebo 58 DCVax R L 58 oblimersen 58 autologous chondrocyte implantation 58 biologic therapy 58 locoregional recurrence 58 Temsirolimus 58 resectable pancreatic cancer 58 methotrexate monotherapy 58 docetaxel Taxotere 58 vivo validation 58 bolus dose 58 vitro maturation 58 immunologically matched 58 choroidal vasculopathy 58 ductal lavage 58 VNP#M 58 Naive Patients 58 dose melphalan 58 posttransplant 58 chimeric monoclonal antibody 58 renal transplant 58 siRNA knockdown 58 gonadotropin releasing hormone GnRH 58 MIBG 58 GRN# 58 cetuximab Erbitux R 58 transplanting stem cells 58 Gleevec imatinib 58 CINTREDEKIN BESUDOTOX 58 bioluminescence imaging 58 unresectable liver cancer 58 treating cancerous tumors 58 KRAS oncogene 58 undetectable HBV DNA 58 coronary stenting 58 pancreatic islet cell 58 chronic GVHD 58 ISF# 58 autologous cells 58 arteriovenous fistula 58 recurrent GBM 58 induce remission 58 pleurodesis 57 weekly subcutaneous injections 57 thrombopoietin TPO natural 57 dose cytarabine 57 mutated KRAS 57 adipose derived stem cells 57 cediranib 57 VFEND 57 temozolomide Temodar 57 metastatic neuroendocrine tumors 57 cryopreserved 57 adjuvant tamoxifen 57 Advagraf 57 Interferon alpha 57 Allovectin 7 57 cellular immunotherapy 57 chimerism 57 laparoscopic radical nephrectomy 57 ovarian stimulation 57 Myelodysplastic Syndrome 57 verteporfin 57 cyclophosphamide methotrexate 57 taxane chemotherapy administered 57 demethylating agent 57 antiangiogenic drugs 57 neoadjuvant treatment 57 trans retinoic acid ATRA 57 plus dacarbazine 57 extracorporeal 57 immunosuppressive regimens 57 pulmonary artery banding 57 sipuleucel T 57 Taxol ® 57 lymph node dissection 57 ablative therapy 57 etanercept Enbrel 57 factor G CSF 57 Dr. Victor Velculescu 57 administered subcutaneously 57 EECP ® therapy 57 chromosomal mutations 57 Arsenic trioxide 57 hepatic resection 57 dasatinib Sprycel ® 57 ABVD 57 BCR ABL inhibitor 57 imexon 57 PEGylated Fab fragment 57 hepatocellular carcinomas 57 bladder tumors 57 intra cytoplasmic sperm 57 transurethral resection 57 BRAF V#E mutation 57 standard chemotherapy regimen 57 PNP inhibitor 57 MVax ® 57 FOLFOX4 57 mRCC 57 trastuzumab Herceptin ® 57 metastatic CRC 57 islet cell 57 Kepivance 57 MMP inhibitors 57 ganciclovir 57 hormone LHRH antagonist 57 interstitial brachytherapy 57 proteasome inhibitor 57 tyrosine kinase inhibitor 57 intravenous bolus 57 rFSH 57 ChronVac C ® 57 clinically localized prostate 57 metaplasia 57 interferon alfa 2b 57 Irinotecan 57 HERCEPTIN 57 adenovirus mediated 57 GHRH 57 NAVISTAR R 57 #Gy 57 Atypical Hemolytic Uremic Syndrome 57 Zevalin consolidation 57 total thyroidectomy 57 OncoVEX 57 Kidney transplantation 57 revascularization procedure 57 AMD# [003] 57 bone marrow stromal cells 57 colon carcinoma 57 refractory chronic lymphocytic 57 refractory acute myeloid 57 CMV seropositive 57 Tamibarotene 57 intracytoplasmic sperm injection 57 intravenous iv 57 immune modulating 57 somatic cell 57 malignant prostate 57 Pemetrexed 57 alefacept 57 Panzem R NCD 57 EGFR receptor 57 metastatic RCC 57 rBChE 57 primordial germ cells 57 Urocidin 57 elacytarabine 57 oral talactoferrin 57 Endologix Powerlink System 57 stage IIIA 57 Avastin Tarceva 57 anthracyclines taxanes 57 Belldegrun 57 hepatic arterial 57 MRgFUS 57 Factor VIIa 57 endocrine therapies 57 alkylating agents 57 solid organ transplantation 57 lung metastases 57 adjuvant therapy 57 relapsed ovarian cancer 57 malignant ascites 57 CMV infections 57 regenerative medicine therapies 57 metastatic renal cell carcinoma 57 aneuploid 57 autologous 57 abacavir Ziagen 57 CRp 57 RAS mutations 57 hypofractionated 57 thymidine 57 fibrinolysis 57 gastrointestinal stromal tumor GIST 57 penetrating keratoplasty 57 hematological relapse 57 pancreatic endocrine 57 decellularization 57 Certolizumab pegol 57 stem cell transplants 57 trastuzumab Herceptin R 57 gemcitabine carboplatin 57 OvaRex MAb 57 NSCLC tumors 57 Xcellerated T Cells 57 ReN# 57 allograft tissue 57 endometrial biopsy 57 cryosurgery 57 oocyte retrieval 57 hepatorenal syndrome 57 pancreatic islet cells 57 #beta HSD1 57 medically inoperable 57 intravenous immunoglobulin 57 CYT# QbG# 57 retinal pigment epithelial cells 57 antithrombotic therapy 57 imatinib Gleevec 57 HepaSphere Microspheres 57 corticosteroid dexamethasone 57 naturally occurring tannins 57 TET2 57 Aptivus ® 57 Adjuvant chemotherapy 57 dacarbazine 57 Xanafide 57 basal cell carcinoma BCC 57 bolus injection 57 generation purine nucleoside 57 ATIR 57 beta islets 57 Mitomycin C 57 fallopian tube carcinoma 57 TLIF 57 temozolomide TMZ 57 GRNVAC1 57 thymosin 57 donor nephrectomy 57 osteoinductive 57 nonsquamous 57 Fludara ® 57 lymphoid malignancies 57 Aflibercept 57 humanized antibody 57 Kit CD# positive 57 rFVIIa 57 renal denervation 57 acellular 57 anthracycline chemotherapy 57 Lilly Gemzar 57 FOLFOX6 57 transplant HSCT 57 alfa 2a 57 kidney pancreas 57 Tarceva TM 57 thoracoscopic 57 Mohs micrographic surgery 57 tumor biopsies 57 OrCel ® 57 subcutaneous immunoglobulin 57 ADAMTS# 57 viral inactivation 57 interferon ribavirin 57 ESBA# 57 Intravenous immunoglobulin 57 refractory CLL 57 intravenous dosing 57 atypical hemolytic uremic syndrome 57 advanced unresectable 57 lymphomas leukemias 57 retroperitoneal 57 insulin secreting beta 57 CardioPass TM 57 Gamunex C 57 hES cells 57 donor pancreases 57 recovery CRp 57 plasmid encoding 57 PrevOnco ™ 57 Circulating tumor cells 57 histologically proven 57 bronchoalveolar lavage fluid 57 ZOLINZA 57 mycophenolate mofetil 57 standard immunosuppressive therapies 57 LHRH antagonist 57 dose escalation phase 57 microdose 57 erlotinib Tarceva 57 esophageal resection 57 leukemia AML 56 cranial irradiation 56 buffy coat 56 Donated organs 56 kallikrein 56 cerebral angiography 56 interleukin IL -# 56 adenovirus vector 56 mda 7 56 DCVax R Brain 56 euglycemic clamp 56 GTC recombinant human 56 NMIBC 56 hematopoietic cancers 56 injected subcutaneously 56 skeletal myoblasts 56 bovine thrombin 56 Bone marrow transplant 56 recurrent NSCLC 56 Trastuzumab 56 baseline LDH 56 microdebrider 56 undifferentiated stem cells 56 idiotype protein 56 Radio Frequency Ablation 56 demonstrated antitumor activity 56 immunosuppression therapy 56 orally administered synthetic retinoid 56 sorafenib Nexavar ® 56 hematopoietic 56 pretransplant 56 Anthracycline 56 removed laparoscopically 56 myelodysplastic myeloproliferative diseases 56 LEUKINE 56 enhanced external counterpulsation 56 Interferon alfa 56 DCVax 56 antibody mediated 56 IRX 2 56 GRNCM1 56 IDO inhibitor 56 metastatic colon cancer 56 Tyrosine Kinase Inhibitors 56 TEMODAL 56 lysophosphatidic acid 56 OPCAB 56 Hematopoietic 56 Autologous stem cell 56 diagnostic biomarker 56 dalteparin 56 tumor recurrence 56 Mitral valve repair 56 Resten MP 56 accumulate preferentially 56 small molecule activators 56 intranasal delivery 56 urethral bulking agent 56 Ebola SNALP 56 docetaxel prednisone 56 letrozole Femara 56 pharmacologically active isomer 56 trastuzumab DM1 T DM1 56 fulvestrant 56 caspofungin 56 Mepact 56 idraparinux 56 Pertuzumab 56 Immunosuppressive drugs 56 operable breast cancer 56 imiquimod cream 56 bilateral orchiectomy 56 HuCNS SC ® 56 anticlotting drugs 56 unresectable stage 56 bleomycin 56 relapsed multiple myeloma 56 function DGF 56 AV grafts 56 eflornithine 56 Aspergillus nidulans 56 KRAS mutations occur 56 bladder augmentation 56 thyroidectomy 56 arterial grafts 56 thyroglobulin 56 intra articular injection 56 ALN TTR# 56 balloon dilation 56 Smac mimetics 56 tyrosine kinase inhibitors TKIs 56 FVIIa 56 liver metastases 56 STEEN Solution ™ 56 granulocyte 56 Flu Cy 56 KRAS mutation 56 LHRH 56 non squamous 56 ANCA associated 56 IVF embryo 56 pancreatic islet 56 JAK3 56 cervical lymph nodes 56 omega interferon 56 GnRH agonist 56 bevacizumab Avastin R 56 Surgical excision 56 antiangiogenesis 56 Myelodysplastic Syndrome MDS 56 occluded artery 56 radical cystectomy 56 vitamin B# folic acid 56 nonmetastatic 56 Acute renal failure 56 cervical lymph node 56 ex vivo 56 severely immunocompromised 56 ASCT 56 immunosuppressant medication 56 HALO# [002] 56 Selective Internal 56 antifungal therapy 56 paracentesis 56 hormone deprivation 56 Intra arterial 56 microinjection 56 CorVue TM 56 metastatic renal cell 56 GVAX ® 56 prostate cancer CRPC 56 Hormonal therapy 56 reimplanted 56 palliation 56 metastatic kidney 56 PET tracers 56 remission induction 56 oxaliplatin Eloxatin 56 gastrointestinal stromal tumor 56 paclitaxel Taxol 56 DFMO 56 recombinant enzyme 56 dexamethasone VAD 56 MMP inhibitor 56 eBx 56 micrometastasis 56 radiation therapy SBRT 56 griseofulvin 56 SomatoKine 56 retroviral vectors 56 recombinant interferon 56 liver transplant recipients 56 cleavable linker 56 #mg ATC 56 Aplidin 56 Peg IFN 56 porcine derived 56 interferon alfa 56 sentinel lymph node biopsy 56 Gemzar gemcitabine 56 immunotoxins 56 Photodynamic therapy PDT 56 CIMZIA ™ 56 INGAP 56 thymosin beta 4 56 transthyretin TTR 56 esophageal gastric 56 Western Blotting 56 non porcine pancreatic 56 Her2/neu 56 vWF 56 pancreatic ductal 56 biotherapy 56 underwent radical cystectomy 56 nonischemic 56 anastrazole 56 opioid analgesia 56 Cojocaru correspondent 56 sorafenib tablets 56 collagenase 56 localized renal 56 Tumors shrank 56 Intravitreal injections 56 pleural fluid 56 dialed Ybarra 56 artery bypass 56 Proleukin 56 pegylated interferon alpha 56 extracorporeal membrane oxygenation 56 dyskeratosis congenita 56 Genasense ® 56 histamine dihydrochloride 56 anti CD3 56 ocular disorders 56 bioartificial liver 56 Peginterferon alfa 2b 56 T1c 56 tumor lysis syndrome 56 hyaluronidase enzyme 56 Revimmune 56 cryo preserved 56 immunosuppressant 56 K RAS 56 Thymoglobulin ® 56 EGFR TKIs 56 Annamycin 56 Balloon sinuplasty 56 intravesical instillation 56 potent antiproliferative 56 thyroid hormone receptor 56 contralateral breast 56 Decitabine 56 Ataluren 56 MyoCell ® 56 photocoagulation 56 OHR/AVR# 56 heavily pretreated patients 56 Adjuvant therapy 56 unmutated 56 Stereotactic Body Radiation Therapy 56 intrathecal chemotherapy 56 dimeglumine 56 noninvasive imaging 56 tyrosine kinase inhibitor TKI 56 ureteral stents 56 Adult Stem Cell Therapy 56 ASC J9 56 fluoropyrimidine 56 OncoVEX GM CSF 56 maximally tolerated lipid lowering 56 Inhaled AAT 56 nilotinib Tasigna ® 56 dedifferentiation 56 surgical revascularization 56 thrombolytics 56 LRAT 56 rituximab Rituxan R 56 pegfilgrastim 56 octreotide LAR 56 contractile muscle 56 OnDose 56 intravenous IV infusion 56 gemcitabine chemotherapy 56 paricalcitol 56 Belatacept 56 bladder carcinoma 56 irinotecan doxorubicin oxaliplatin paclitaxel 56 bone morphogenetic proteins 56 pegylated interferon alpha 2a 56 VATS lobectomy 56 severe neutropenia 56 lung resection 56 IFN alpha 2a 56 capecitabine Xeloda 56 reinfused 56 Nexavar sorafenib 56 cartilage regeneration 56 drug DMARD 56 Bayer HealthCare Onyx Pharmaceuticals 56 Revascor TM 56 synthetic grafts 56 human leukocyte antigens 56 mitomycin C 56 Intensity modulated radiation 56 Hedgehog inhibitor 56 SCCHN 56 receptor inhibitor 56 LCP Tacro 56 decortication 56 ZFP TF 56 renoprotective 56 HLA markers 56 vinorelbine tartrate 56 refractory ovarian cancer 56 Mitoxantrone 56 epithelial tumors 56 CMV disease 56 Folfox 56 CDDO Im 56 mitral valve replacement 56 pancreaticoduodenectomy 56 palliative radiotherapy 56 prostate carcinomas 56 posttranslational modification 56 renal transplants 56 argatroban 56 weekly intravenous infusions 56 undergo lumpectomy 56 renal biopsy 56 5 FU leucovorin 56 AMEVIVE 56 percutaneous cryoablation 56 intracytoplasmic sperm injection ICSI